41964-65-2

Basic information

• Product Name: 2-BROMO-N-(3-CHLORO-PHENYL)-ACETAMIDE
• Synonyms: 2-BROMO-N-(3-CHLORO-PHENYL)-ACETAMIDE;AKOS BB/0108;CHEMBRDG-BB 4023660;AKOS BBB/460;acetamide, 2-bromo-N-(3-chlorophenyl)-;2-bromo-N-(3-chlorophenyl)acetamide(SALTDATA: FREE);2-bromo-N-(3-chlorophenyl)ethanamide;Acetamide, N-(3-chlorophenyl)-2-bromo-
• CAS NO: 41964-65-2
• Molecular Formula: C₈H₇BrClNO
• Molecular Weight: 248.5
• Mol File: 41964-65-2.mol
• Article Data: 29

Chemical Properties

• Boiling Point: 377.7°C at 760 mmHg
• Flash Point: 182.2°C
• Appearance: /
• Density: 1.683g/cm³
• Vapor Pressure: 6.64E-06mmHg at 25°C
• Refractive Index: 1.639
• CAS DataBase Reference: 2-BROMO-N-(3-CHLORO-PHENYL)-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-N-(3-CHLORO-PHENYL)-ACETAMIDE(41964-65-2)
• EPA Substance Registry System: 2-BROMO-N-(3-CHLORO-PHENYL)-ACETAMIDE(41964-65-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 41964-65-2(Hazardous Substances Data)

Usage

Preparation

A clean iodine flask of 250 ml was taken. 10ml solution of freshly prepared 10% solution of sodium carbonate was added to the flask followed by the addition of 0.1 ml of 3- chloro aniline. Shake the flask to mix it properly. Then bromoacetyl bromide was added gradually. Again shake it vigorously until ppts appeared. Precipitates were filtered and proper washing was done. Dry the precipitates and product purity was checked by TLC. Amount was calculated & packed.

InChI:InChI=1/C8H7BrClNO/c9-5-8(12)11-7-3-1-2-6(10)4-7/h1-4H,5H2,(H,11,12)

Upstream product

• 22118-09-8 2-bromoacetyl chloride 
• 108-42-9 3-chloro-aniline 
• 598-21-0 2-Bromoacetyl bromide 
• 121-44-8 triethylamine 
• 79-08-3 bromoacetic acid 

Downstream Products

• 1019401-22-9 1-[(3-chloro-phenylcarbamoyl)-methyl]-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 
• 1019400-24-8 C₁₅H₁₆ClN₃O₃ 
• 1132817-48-1 N-(3-chlorophenyl)-2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}acetamide 
• 1009561-44-7 C₆₁H₁₀₅ClN₄O₁₅Si₂ 
• 1393643-06-5 N-hydroxy-4-{[(3-chlorophenylcarbamoylmethyl)amino]methyl}benzamide 
• 1009879-01-9 N-(3-chlorophenyl)-2-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-1-yl)acetamide 
• 638997-56-5 C₁₅H₁₂ClN₃OS₂ 
• 1550168-77-8 2-(4-((3-amino-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(3-chlorophenyl)acetamide 
• 383895-84-9 3-amino-N-(3'-chlorophenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide 
• 902509-19-7 4-oxo-N-(3-chlorophenyl)-[1]benzopyrano[4,3-c]pyrazole-1(4H)acetamide 
• 1412441-74-7 C₈H₁₀ClN₃O 

Relevant articles and documents

Novel monoacylglycerol lipase inhibitor as well as preparation method and application thereof

The invention discloses a novel monoacylglycerol lipase inhibitor as well as a preparation method and application thereof. Specifically, the invention provides a compound shown as a formula I, or a pharmaceutically acceptable salt, a stereoisomer, or a deuterated derivative thereof. Experimental results show that the compound provided by the invention can effectively inhibit MAGL activity, can beused for preparing an MAGL inhibitor and preparing medicines for preventing and/or treating diseases (including endometrial cancer, colorectal cancer, liver cancer, breast cancer, ovarian cancer, neurodegenerative diseases and the like) related to abnormal MAGL activity, and has a wide application prospect.

Synthesis and Cytotoxic Evaluation of Some New 1,2,3-Triazole Linked 2-Imino-4-(Trifuoromethyl)-Thiazolidin-4-ol Derivatives

A new series of 1,2,3-triazole tagged 2-imino-4-(trifluoromethyl)thiazolidinol derivatives was synthesized through click chemistry under Sharpless conditions and evaluated for anticancer activity against human monocytic leukemia (U937), human breast adeno

Synthesis, anticancer, and computational studies of 1, 3, 4-oxadiazole-purine derivatives

Theophylline-7-acetic acid (acefylline) (3) and its derivatives are pharmacologically active compounds and generally recognized as bronchodilators for the treatment of respiratory diseases like acute asthma for over 70 years. In this article, synthesis of